Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents.Read More
Imaging manufacturer Guerbet faces financial challenges following recent FDA warning
Related Posts
Add A Comment
